Pancreatic Cancer Research

ResearcherJiangnan UniversityActive in the last 2 years

Fang‐Ming Chen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-5427-6868; OpenAlex author ID A5053073149. Sources: OpenAlex.

Their work

Papers
12 (first author 2, last author 3)
Trials
0
Grants
0
Labs led
2
Collaborators
18
Papers, trials and grants by year

2016: 1 paper · 2017: 1 paper · 2018: none · 2019: none · 2020: 2 papers · 2021: 1 paper · 2022: none · 2023: 2 papers · 2024: none · 2025: 2 papers · 2026: 3 papers

Papers 12

  1. CT-based Node-RADS for evaluating regional lymph node metastasis and postoperative recurrence in patients with pancreatic ductal adenocarcinoma undergoing upfr… Co-author DOI 10.1007/s00330-026-12564-x↗
  2. CT-derived body composition predicts futile upfront resection in pancreatic cancer: a multicenter study. Last author DOI 10.1007/s00330-026-12643-z↗
  3. Comparison of Node-RADS for regional lymph node metastasis in pancreatic ductal adenocarcinoma via CT and MRI. First author DOI 10.1016/j.ejrad.2026.112879↗
  4. Combination of imaging features on pancreatic CT for predicting early recurrence after upfront pancreatoduodenectomy of pancreatic ductal adenocarcinoma. Last author DOI 10.1016/j.ejro.2025.100672↗
  5. Differentiating pancreatic from periampullary non-pancreatic cancer: a nomogram-based prediction model utilizing CT imaging. Co-author DOI 10.1186/s40644-025-00917-6↗
  6. A CT Radiomics-Based Risk Score for Preoperative Estimation of Intraoperative Superior Mesenteric-Portal Vein Involvement in Pancreatic Ductal Adenocarcinoma. Last author DOI 10.1245/s10434-022-12664-0↗
  7. ASO Author Reflections: Estimation of Intraoperative Superior Mesenteric-Portal Vein Involvement in Pancreatic Ductal Adenocarcinoma on Preoperative CT-Radiomi… First author DOI 10.1245/s10434-022-12713-8↗
  8. CT texture analysis for the presurgical prediction of superior mesenteric-portal vein invasion in pancreatic ductal adenocarcinoma: comparison with CT imaging … Co-author DOI 10.1016/j.crad.2021.01.003↗
  9. Upregulation of ARHGAP30 attenuates pancreatic cancer progression by inactivating the β-catenin pathway. Co-author DOI 10.1186/s12935-020-01288-7↗
  10. Radiomics-Assisted Presurgical Prediction for Surgical Portal Vein-Superior Mesenteric Vein Invasion in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3389/fonc.2020.523543↗
  11. Prediction of Vascular Invasion Using a 3-Point Scale Computed Tomography Grading System in Pancreatic Ductal Adenocarcinoma: Correlation With Surgery. Co-author DOI 10.1097/rct.0000000000000530↗
  12. Presurgical Evaluation of Pancreatic Cancer: A Comprehensive Imaging Comparison of CT Versus MRI. Co-author DOI 10.2214/ajr.15.15236↗

Closest collaborators

The 18 strongest of 18 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yongping Zhou · 8 shared papers, 2020–2026 · strength 2.04
  2. Xiangpan Meng · 3 shared papers, 2026 · strength 0.95
  3. Jing Xu · 2 shared papers, 2026 · strength 0.67
  4. Gui-Xue Dai · 2 shared papers, 2025–2026 · strength 0.55
  5. Hao Wang · 2 shared papers, 2023–2025 · strength 0.46
  6. Lei Zhang · 3 shared papers, 2016–2025 · strength 0.43
  7. Xiaohuan Zhang · 1 shared paper, 2025 · strength 0.28
  8. Lei Zhang · 1 shared paper, 2025 · strength 0.28
  9. Shuanglin Zhang · 1 shared paper, 2025 · strength 0.27
  10. Yong Yan · 1 shared paper, 2023 · strength 0.19
  11. Chunjuan Jiang · 2 shared papers, 2016–2017 · strength 0.15
  12. Bin Li · 2 shared papers, 2016–2017 · strength 0.15
  13. L. Zhang · 1 shared paper, 2021 · strength 0.14
  14. Lei Zhang · 1 shared paper, 2020 · strength 0.13
  15. Zhiyuan Hua · 1 shared paper, 2020 · strength 0.12
  16. Tu Dai · 1 shared paper, 2020 · strength 0.12
  17. Liying Wang · 1 shared paper, 2020 · strength 0.12
  18. Chunhong Hu · 1 shared paper, 2017 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.